Differential regulation of PHEX expression in bone and parathyroid gland by chronic renal insufficiency and 1,25-dihydroxyvitamin D3

American Journal of Physiology - Renal Physiology

Volumn 286, Issue 4 55-4, 2004, Pages

  Brewer, Angela J ^a,c   Canaff, Lucie ^b   Hendy, Geoffrey N ^a,b   Tenenhouse, Harriet S ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Endopeptidase; Hyperphosphatemia; Parathyroid hormone

Indexed keywords

CALCITRIOL; GENE PRODUCT; PROTEIN PHEX; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE MINERALIZATION; BONE TISSUE; CHRONIC KIDNEY FAILURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; GENE MUTATION; HYPERPARATHYROIDISM; MALE; NEPHRECTOMY; NONHUMAN; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PHEX GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TIBIA; VITAMIN D RESISTANT RICKETS; WASTING SYNDROME;

EID: 1642379621     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00321.2003     Document Type: Article

References (44)

1. Bai X, Miao D, Panda D, Grady S, McKee MD, Goltzman D, and Karaplis AC. Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) expression. Mol Endocrinol 16: 2913-2925, 2002.
2. Beck L, Soumounou Y, Martel J, Krishnamurthy G, Gauthier C, Goodyer C, and Tenenhouse HS. Pex/PEX tissue distribution and evidence for a deletion in the 3′ region of the Pex gene in X-linked hypophosphatemic mice. J Clin Invest 99: 1200-1209, 1997.
3. Blydt-Hansen TD, Tenenhouse HS, and Goodyer P. PHEX expression in parathyroid gland and PTH dysregulation in X-linked hypophosphatemia. Pediatr Nephrol 13: 607-611, 1999.
4. i and phosphate as inhibitors. Biochem J 355: 707-713, 2001.
5. Bover J, Rodriguez M, Trinidad P, Jara A, Martinez ME, Machado L, Llach F, and Felsenfeld AJ. Factors in the development of secondary hyperparathyroidism during graded renal failure in the rat. Kidney Int 45: 953-961, 1994.
6. Campos M, Couture C, Hirata IY, Juliano MA, Loisel TP, Crine P, Juliano L, Boileau G, and Carmona AK. Human recombinant PHEX has a strict S1′ specificity for acidic residues and cleaves peptides derived from FGF-23 and MEPE. Biochem J 373: 271-279, 2003.
7. Canaff L, Bennett HPJ, Hou Y, Seidah NG, and Hendy GN. Propara-thyroid hormone processing by the proprotein convertase-7: comparison with furin and assessment of modulation of parathyroid convertase messenger ribonucleic acid levels by calcium and 1,25-dihydroxyvitamin D. Endocrinology 140: 3633-3642, 1999.
8. Du L, Desbarats M, Viel J, Glorieux FH, Cawthorn C, and Ecarot B. cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone. Genomics 36: 22-28, 1996.
9. Dubois SG, Ruchon AF, Delalandre A, Boileau G, and Lajeunesse D. Role of abnormal neutral endopeptidase-like activities in Hyp mouse bone cells in renal phosphate transport. Am J Physiol Cell Physiol 283: C1414-C1421, 2002.
10. 3 down-regulates expression of Phex, a marker of the mature osteoblast. Endocrinology 140: 1192-1199, 1999.
11. Ecarot B, Glorieux FH, Desbarats M, Travers R, and Labelle L. Defective bone formation by Hyp mouse bone cells transplanted into normal mice: evidence in favor of an intrinsic osteoblast defect. J Bone Miner Res 7: 215-220, 1992.
12. Green J, Debby H, Lederer E, Levi M, Zajicek HK, and Bick T. Evidence for a PTH-independent humoral mechanism in post-transplant hypophosphatemia and phosphaturia. Kidney Int 60: 1182-1196, 2001.
13. Hines ER, Collins JF, Jones MD, Serey SH, and Ghishan FK. Glucocorticoid regulation of the murine PHEX gene. Am J Physiol Renal Physiol 283: F356-F363, 2002.
14. Hoag HM, Martel J, Gauthier C, and Tenenhouse HS. Effects of Npt2 gene ablation and low-phosphate diet on renal Na/phosphate cotransport and cotransporter gene expression. J Clin Invest 104: 679-686, 1999.
15. Hruska KA and Teitelbaum SL. Renal osteodystrophy. N Engl J Med 333: 166-174, 1995.
16. HYP Consortium. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11: 130-136, 1995.
17. Iorio RJ, Bell WA, Meyer MH, and Meyer RA Jr. Radiographic evidence of craniofacial and dental abnormalities in the X-linked hypophosphatemic mouse. Ann Dent 38: 31-37, 1979.
18. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang M, Miyauchi A, Econs M, Lavigne J, and Jueppner H. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348: 1656-1663, 2002.
19. Kilav R, Silver J, and Naveh-Many T. Parathyroid hormone gene expression in hypophosphatemic rats. J Clin Invest 96: 327-333, 1995.
20. Kumar R, Haugen JD, Wieben ED, Londowski JM, and Cai Q. Inhibitors of renal epithelial phosphate transport in tumor-induced osteomalacia and uremia. Proc Assoc Am Physicians 107: 296-305, 1995.
21. Lipman ML, Panda D, Bennett HPJ, Henderson JE, Shane E, Shen Y, Goltzman D, and Karaplis AC. Cloning of human Pex cDNA. Expression, subcellular localization, and endopeptidase activity. J Biol Chem 273: 13729-13737, 1998.
22. Liu S, Guo R, and Quarles LD. Cloning and characterization of the proximal murine Phex promoter. Endocrinology 142: 3987-3995, 2001.
23. Liu S, Guo R, Tu Q, and Quarles LD. Overexpression of Phex in osteoblasts fails to rescue the Hyp mouse phenotype. J Biol Chem 277: 3686-3697, 2002.
24. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
25. Meyer RA Jr, Meyer MH, and Gray RW. Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice. J Bone Miner Res 4: 493-500, 1989.
26. Meyer RA Jr, Tenenhouse HS, Meyer MH, and Klugerman AH. The renal phosphate transport defect in normal mice parabiosed to X-linked hypophosphatemic mice persists after parathyroidectomy. J Bone Miner Res 4: 523-532, 1989.
27. Miao D, Bai X, Panda D, McKee M, Karaplis A, and Goltzman D. Osteomalacia in hyp mice is associated with abnormal phex expression and with altered bone matrix protein expression and deposition. Endocrinology 142: 926-939, 2001.
28. Miller MA, Chin J, Miller SC, and Fox J. Disparate effects of mild, moderate, and severe secondary hyperparathyroidism on cancellous and cortical bone in rats with chronic renal insufficiency. Bone 23: 257-266, 1998.
29. Miyamura T, Tanaka H, Inoue M, Ichinose Y, and Seino Y. The effects of bone marrow transplantation on X-linked hypophosphatemic mice. J Bone Miner Res 15: 1451-1458, 2000.
30. Nesbitt T, Coffman TM, Griffiths R, and Drezner MK. Cross-transplantation of kidneys in normal and Hyp mice: evidence that the Hyp phenotype is unrelated to an intrinsic renal defect. J Clin Invest 89: 1453-1459, 1992.
31. Qiu ZQ, Tenenhouse HS, and Scriver CR. Parental origin of mutant allele does not explain absence of gene dose in X-linked Hyp mice. Genet Res 62: 39-43, 1993.
32. Qiu ZQ, Travers R, Rauch F, Glorieux FH, Scriver CR, and Tenenhouse HS. Effect of gene dose and parental origin on bone histomorphometry in X-linked Hyp mice. Bone 34: 134-139, 2004.
33. Ruchon AF, Marcinkiewicz M, Siegfried G, Tenenhouse HS, Des-Groseillers L, Crine P, and Boileau G. Pex mRNA is localized in developing mouse osteoblasts and odontoblasts. J Histochem Cytochem 46: 459-468, 1998.
34. Ruchon AF, Tenenhouse HS, Marcinkiewicz M, Siegfried G, Aubin JE, DesGroseillers L, Crine P, and Boileau G. Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers. J Bone Mineral Res 15: 1440-1450, 2000.
35. Scriver CR and Tenenhouse HS. Conserved loci on the X chromosome confer phosphate homeostasis in mice and humans. Genet Res 56: 141-152, 1990.
36. Soliman E, Canaff L, Fox J, and Hendy GN. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency. Endocrinology 138: 2596-2600, 1997.
37. Tenenhouse HS. X-linked hypophosphatemia: a homologous disorder in humans and mice. Nephrol Dial Transplant 14: 333-341, 1999.
38. Tenenhouse HS and Econs MJ. Mendelian hypophosphatemias. In: The Metabolic and Molecular Bases of Inherited Disease, edited by Scriver CR, Beaudet AL, Sly WS, and Valle D. New York: McGraw-Hill, 2001, p. 5039-5067.
39. Thompson DL, Sabbagh Y, Tenenhouse HS, Roche PC, Drezner MK, Salisbury JL, Grande JP, Poeschla EM, and Kumar R. Ontogeny of Phex/PHEX protein expression in mouse embryo and subcellular localization in osteoblasts. J Bone Miner Res 17: 311-320, 2002.
40. Turner AJ and Tanzawa K. Mammalian membrane metallopeptidases: NEP, ECE, KELL and PEX. FASEB J 11: 355-364, 1997.
41. Wang LQ, Du LS, and Ecarot B. Evidence for Phex haploinsufficiency in murine X-linked hypophosphatemia. Mamm Genome 10: 385-389, 1999.
42. Weber TJ, Liu S, Indridason OS, and Quarles LD. Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res 18: 1227-1234, 2003.
43. Whyte MP, Schrank FW, and Armamento-Villareal R. X-linked hypophosphatemia: a search for gender, race, anticipation, or parent of origin effects on disease expression in children. J Clin Endocrinol Metab 81: 4075-4080, 1996.
44. 3 production in hypophysectomized rats. Eur J Endocrinol 146: 97-105, 2002.